{"id":2492,"date":"2026-10-04T08:18:01","date_gmt":"2026-10-04T00:18:01","guid":{"rendered":"https:\/\/haematology.org.my\/?page_id=2492"},"modified":"2026-10-04T08:21:11","modified_gmt":"2026-10-04T00:21:11","slug":"msia-cpg","status":"publish","type":"page","link":"https:\/\/haematology.org.my\/?page_id=2492","title":{"rendered":"Malaysian CPG"},"content":{"rendered":"<p>[et_pb_section fb_built=\"1\" theme_builder_area=\"post_content\" _builder_version=\"4.27.9\" _module_preset=\"default\"][et_pb_row _builder_version=\"4.27.9\" _module_preset=\"default\" theme_builder_area=\"post_content\"][et_pb_column _builder_version=\"4.27.9\" _module_preset=\"default\" type=\"4_4\" theme_builder_area=\"post_content\"][et_pb_text _builder_version=\"4.27.9\" _module_preset=\"default\" theme_builder_area=\"post_content\" header_3_text_color=\"#a5002a\" header_3_font_size_last_edited=\"on|desktop\" header_3_font_size=\"20px\" hover_enabled=\"0\" sticky_enabled=\"0\" header_3_font_size_phone=\"16px\" text_text_color=\"#000000\" text_font_size_last_edited=\"on|phone\" text_font_size_phone=\"14px\" header_3_font_size_tablet=\"20px\"]<\/p>\n<h3>Malaysian Clinical Practice Guidelines<\/h3>\n<p>This page brings together Malaysian Clinical Practice Guidelines (CPGs) relevant to haematology practice. Developed through the Malaysian Health Technology Assessment Section (MaHTAS) and its technical committees, these guidelines translate the best available evidence into recommendations appropriate to the Malaysian healthcare setting, taking into account local clinical practice, resources and healthcare needs.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\"4.27.9\" _module_preset=\"default\" theme_builder_area=\"post_content\"][et_pb_column _builder_version=\"4.27.9\" _module_preset=\"default\" type=\"4_4\" theme_builder_area=\"post_content\"][et_pb_accordion _builder_version=\"4.27.9\" _module_preset=\"default\" theme_builder_area=\"post_content\" hover_enabled=\"0\" sticky_enabled=\"0\"][et_pb_accordion_item title=\"Management Of Myeloproliferative Neoplasms (2nd Edition) 2025\" _builder_version=\"4.27.9\" _module_preset=\"default\" open=\"on\" theme_builder_area=\"post_content\" hover_enabled=\"0\" sticky_enabled=\"0\"]<\/p>\n<p><a href=\"https:\/\/haematology.org.my\/wp-content\/uploads\/2026\/10\/CPG_Management_Of_Myeloproliferative_Neoplasms_Second_Edition_2025_compressed.pdf\" rel=\"attachment wp-att-2499\">eCPG MPN 2025<\/a>\u00a0 pdf 2.8Mb<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=\"Management of Thalassemia (2nd Edition) 2024\" _builder_version=\"4.27.9\" _module_preset=\"default\" open=\"off\" theme_builder_area=\"post_content\" hover_enabled=\"0\" sticky_enabled=\"0\"]<\/p>\n<p><a href=\"https:\/\/haematology.org.my\/wp-content\/uploads\/2026\/10\/e-CPG_Thalas-16_8_25.pdf\" rel=\"attachment wp-att-2500\">e-CPG_Thalassemia 2024<\/a>\u00a0 pdf 15.4Mb<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=\"Management of Cancer Pain (2nd Edition) 2023\" _builder_version=\"4.27.9\" _module_preset=\"default\" theme_builder_area=\"post_content\" hover_enabled=\"0\" sticky_enabled=\"0\"]<\/p>\n<p><a href=\"https:\/\/haematology.org.my\/wp-content\/uploads\/2026\/10\/cancerpain.pdf\" rel=\"attachment wp-att-2497\">eCPG cancerpain 2023<\/a>\u00a0 pdf 4.6Mb<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=\"Management Of Haemophilia 2018\" _builder_version=\"4.27.9\" _module_preset=\"default\" theme_builder_area=\"post_content\" hover_enabled=\"0\" sticky_enabled=\"0\"]<\/p>\n<p><a href=\"https:\/\/haematology.org.my\/wp-content\/uploads\/2026\/10\/CPG-haemophilia-201119.pdf\" rel=\"attachment wp-att-2498\">eCPG haemophilia 2018<\/a>\u00a0 pdf 18.6 Mb<\/p>\n<p>[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Malaysian Clinical Practice Guidelines This page brings together Malaysian Clinical Practice Guidelines (CPGs) relevant to haematology practice. Developed through the Malaysian Health Technology Assessment Section (MaHTAS) and its technical committees, these guidelines translate the best available evidence into recommendations appropriate to the Malaysian healthcare setting, taking into account local clinical practice, resources and healthcare needs.eCPG [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-2492","page","type-page","status-publish","hentry"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/haematology.org.my\/index.php?rest_route=\/wp\/v2\/pages\/2492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haematology.org.my\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/haematology.org.my\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/haematology.org.my\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haematology.org.my\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2492"}],"version-history":[{"count":7,"href":"https:\/\/haematology.org.my\/index.php?rest_route=\/wp\/v2\/pages\/2492\/revisions"}],"predecessor-version":[{"id":2511,"href":"https:\/\/haematology.org.my\/index.php?rest_route=\/wp\/v2\/pages\/2492\/revisions\/2511"}],"wp:attachment":[{"href":"https:\/\/haematology.org.my\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}